Home/Filings/4/0000899243-22-022013
4//SEC Filing

TEPPER ROBERT I 4

Accession 0000899243-22-022013

CIK 0001628171other

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 7:07 PM ET

Size

12.7 KB

Accession

0000899243-22-022013

Insider Transaction Report

Form 4
Period: 2022-06-08
Transactions
  • Sale

    Common Stock

    2022-06-08$20.25/sh419,901$8,502,9955,104,130 total
Holdings
  • Common Stock

    (indirect: See footnote)
    0
  • Common Stock

    129,258
Transactions
  • Sale

    Common Stock

    2022-06-08$20.25/sh419,901$8,502,9955,104,130 total
Holdings
  • Common Stock

    (indirect: See footnote)
    0
  • Common Stock

    129,258
Transactions
  • Sale

    Common Stock

    2022-06-08$20.25/sh419,901$8,502,9955,104,130 total
Holdings
  • Common Stock

    (indirect: See footnote)
    0
  • Common Stock

    129,258
Transactions
  • Sale

    Common Stock

    2022-06-08$20.25/sh419,901$8,502,9955,104,130 total
Holdings
  • Common Stock

    (indirect: See footnote)
    0
  • Common Stock

    129,258
Footnotes (4)
  • [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.25 to $20.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
  • [F2]These shares are directly held by Third Rock Ventures III, L.P. ("TRV III"). The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III"). The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual manager of TRV GP III LLC is Dr. Robert Tepper ("Tepper"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares
  • [F3]Third Rock Ventures IV, L.P. ("TRV IV") directly holds 1,419,900 shares of Common Stock of the Issuer. The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of the reporting persons and TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.
  • [F4]The shares are directly held by Tepper.

Issuer

Revolution Medicines, Inc.

CIK 0001628171

Entity typeother

Related Parties

1
  • filerCIK 0001192595

Filing Metadata

Form type
4
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 7:07 PM ET
Size
12.7 KB